MaxCyte (MXCT) has released an update.
MaxCyte, Inc., a leader in cell-engineering technologies, announced its participation in two significant investor conferences this November. The company will engage in fireside chats at both the Stifel 2024 Healthcare Conference and the Stephens Annual Investment Conference, providing insights into its innovative platforms that drive the cell therapy market.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
